Sign in Subscribe
Prime ministers

UK Government Forms Taskforce to Develop Antiviral Medications Amid Rising COVID-19 Cases

Strategic Insights

— 1 min read

The UK government has announced the formation of a taskforce to develop antiviral medications that could help reduce infections and limit the impact of new variants of COVID-19. The taskforce aims to "supercharge" the search for antiviral medications before the winter, when respiratory diseases are more prevalent. These medications could provide a further line of medical defence against the expected third wave of the virus.

Key Takeaways:

  • The UK government has formed a taskforce to develop antiviral medications that could help reduce infections and limit the impact of new variants of COVID-19.
  • The taskforce will support the development of the drugs through clinical trials and also look at manufacturing opportunities.
  • According to Dr. Nikita Kanani, medical director of primary care for NHS England, the NHS is working internationally to identify effective treatments for COVID-19.
  • There are already several treatments being tested and refined, with a positive research finding being implemented in practice within six days.
  • The taskforce aims to find a treatment that can be taken at home to stop the virus in its tracks, reducing the chance of infection turning into severe disease.
  • The UK government is also working on booster jabs, continued testing, and other measures to combat the expected third wave of COVID-19.
  • The UK has recorded 33 deaths within 28 days of a positive coronavirus test, bringing the country's total to 127,307.
  • The Office for National Statistics (ONS) reported a total of 379 deaths registered in England and Wales in the week ending April 9, the lowest number since the week ending October 2.
  • There were 2,524 new cases of coronavirus recorded yesterday, and 43,457,910 jabs have been given in the UK so far, with 33,032,120 being first doses and 10,425,790 being second doses.

Sources:

  • [Boris Johnson, UK Prime Minister, quoted in the article]
  • [Dr. Nikita Kanani, medical director of primary care for NHS England, quoted in the article]
  • [Office for National Statistics (ONS), reported in the article]
  • [Government data up to April 19, reported in the article]
  • [Sir Patrick Vallance, UK Government's chief scientific adviser, quoted in the article]

Read more